CIK 0001160308 · Non-accelerated filer<br>Smaller reporting company
Savara Inc
Sign in to watch- Ticker
- SVRA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 841318182
- Phone
- 51285113796
- Business address
- 6836 BEE CAVE ROAD, BUILDING 3, SUITE 201, AUSTIN, TX, 78746
- Former names
- Mast Therapeutics, Inc., ADVENTRX PHARMACEUTICALS INC, BIOKEYS PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-12-12 | Lutz Robert Matthew Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +300,000 | 300,000 | ||
| 2024-12-12 | Lowrance David L Chief Financial Officer | Grant or award | +100,000 | 442,355 | ||
| 2024-12-12 | Lowrance David L Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +300,000 | 300,000 | ||
| 2024-12-12 | Pratt Raymond Dennis Chief Medical Officer | Grant or award | +80,000 | 340,050 | ||
| 2024-12-12 | Pratt Raymond Dennis Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +280,000 | 280,000 | ||
| 2024-12-12 | Pauls Matthew CHIEF EXECUTIVE OFFICER | Grant or award | +400,000 | 1,683,674 | ||
| 2024-12-12 | Pauls Matthew CHIEF EXECUTIVE OFFICER | Grant or award · Stock Option (Right to Buy) | +900,000 | 900,000 | ||
| 2024-12-12 | Hawkins Richard J Director | Grant or award | +40,000 | 75,241 | ||
| 2024-12-12 | Elam Nevan C Director | Grant or award | +40,000 | 62,500 | ||
| 2024-12-12 | van Es-Johansson An Director | Grant or award | +40,000 | 62,500 | ||
| 2024-12-12 | McCracken Joseph S Director | Grant or award | +40,000 | 250,837 | ||
| 2024-12-12 | RAMSAY DAVID A Director | Grant or award | +40,000 | 2,363,642 | ||
| 2024-11-19 | McCracken Joseph S Director | Purchase | +20,000 | $2.95 | $59K | 210,837 |
| 2024-11-18 | RAMSAY DAVID A Director | Purchase | +100,000 | $2.88 | $288K | 2,323,642 |
| 2024-11-10 | Pratt Raymond Dennis Chief Medical Officer | Shares withheld for taxes | −49,950 | $3.97 | $198K | 260,050 |
| 2024-10-21 | Erickson Anne Chief Business Officer | Shares withheld for taxes | −381 | $3.57 | $1K | 352,935 |
| 2024-09-25 | Parker Braden C. Chief Commercial Officer | Grant or award | +85,000 | 85,000 | ||
| 2024-09-25 | Parker Braden C. Chief Commercial Officer | Grant or award · Stock Option (Right to Buy) | +170,000 | 170,000 | ||
| 2024-07-21 | Erickson Anne Chief Business Officer | Shares withheld for taxes | −381 | $4.47 | $2K | 353,316 |
| 2024-04-21 | Erickson Anne Chief Business Officer | Shares withheld for taxes | −381 | $4.81 | $2K | 353,697 |
Page 5 of 11 · 202 trades